Kun Shi

956 total citations
36 papers, 712 citations indexed

About

Kun Shi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Kun Shi has authored 36 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Kun Shi's work include Pulmonary Hypertension Research and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Spine and Intervertebral Disc Pathology (5 papers). Kun Shi is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Spine and Intervertebral Disc Pathology (5 papers). Kun Shi collaborates with scholars based in China, Netherlands and United States. Kun Shi's co-authors include Thomas S. C. Farrell, C. Arnold Spek, Karla Queiroz, Dick J. Richel, Fengzhen Wang, Carel J.M. van Noesel, JanWillem Duitman, Jingcheng Wang, Johanna W. Wilmink and Dongsheng Zhang and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Kun Shi

34 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Shi China 16 156 126 108 104 81 36 712
Peyman Dinarvand United States 18 223 1.4× 163 1.3× 335 3.1× 51 0.5× 151 1.9× 31 1.1k
Yvonne Förster Germany 13 130 0.8× 29 0.2× 135 1.3× 74 0.7× 76 0.9× 19 604
Timo Rademakers Netherlands 16 226 1.4× 62 0.5× 142 1.3× 76 0.7× 87 1.1× 32 782
T. N. Dugina Russia 13 97 0.6× 136 1.1× 78 0.7× 34 0.3× 18 0.2× 32 456
Shinji Asakura Japan 15 150 1.0× 136 1.1× 59 0.5× 170 1.6× 40 0.5× 35 581
Luca Pontiggia Switzerland 17 190 1.2× 46 0.4× 142 1.3× 31 0.3× 66 0.8× 34 818
Peng Chang China 14 123 0.8× 29 0.2× 124 1.1× 42 0.4× 18 0.2× 37 670
Gyu Ha Ryu South Korea 13 192 1.2× 22 0.2× 83 0.8× 48 0.5× 64 0.8× 40 596
Haneen Sadick Germany 22 187 1.2× 22 0.2× 425 3.9× 314 3.0× 109 1.3× 75 1.2k
Doris Greiling United Kingdom 9 137 0.9× 35 0.3× 84 0.8× 47 0.5× 39 0.5× 11 576

Countries citing papers authored by Kun Shi

Since Specialization
Citations

This map shows the geographic impact of Kun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Shi more than expected).

Fields of papers citing papers by Kun Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Shi. The network helps show where Kun Shi may publish in the future.

Co-authorship network of co-authors of Kun Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Shi. A scholar is included among the top collaborators of Kun Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Shi. Kun Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Kun, Tao Li, Xulin Hu, et al.. (2025). Injectable and Sprayable Thermoresponsive Hydrogel with Fouling‐Resistance as an Effective Barrier to Prevent Postoperative Cardiac Adhesions. Advanced Science. 12(23). e2500731–e2500731. 4 indexed citations
2.
Shi, Kun, et al.. (2025). Revealing the role of regulatory b cells in cancer: development, function and treatment significance. Cancer Immunology Immunotherapy. 74(4). 125–125. 3 indexed citations
3.
He, Juan, Yuxin Zhang, Rui Dong, et al.. (2025). FXR protects against neonatal sepsis by enhancing the immunosuppressive function of MDSCs. Cellular and Molecular Immunology. 22(6). 661–673. 2 indexed citations
6.
Jiang, Yulin, Kun Shi, Miaomiao He, et al.. (2022). 3D-printed auxetic-structured intervertebral disc implant for potential treatment of lumbar herniated disc. Bioactive Materials. 20. 528–538. 76 indexed citations
7.
Wang, Juehan, Leizhen Huang, Xi Yang, et al.. (2021). The Regulatory Effect of MicroRNA‐101‐3p on Disc Degeneration by the STC1/VEGF/MAPK Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 1073458–1073458. 8 indexed citations
8.
Wang, Xianmin, et al.. (2021). Predictive value of brachial artery flow-mediated dilation on coronary artery abnormality in acute stage of Kawasaki disease. Scientific Reports. 11(1). 8162–8162. 3 indexed citations
9.
Dong, Hui, et al.. (2021). Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan. American Journal of Hypertension. 34(1). 121–121. 5 indexed citations
10.
Zhang, Jianwei, et al.. (2021). Subarachnoid hemorrhage after full endoscopic transforaminal lumbar interbody fusion: a case report. British Journal of Neurosurgery. 37(6). 1757–1760. 2 indexed citations
11.
Wang, Jingcheng, Yizhou Huang, Leizhen Huang, et al.. (2020). Novel biomarkers of intervertebral disc cells and evidence of stem cells in the intervertebral disc. Osteoarthritis and Cartilage. 29(3). 389–401. 26 indexed citations
12.
Shi, Kun, et al.. (2017). Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice. Molecular Medicine. 23(1). 13–23. 19 indexed citations
13.
Shi, Kun, et al.. (2015). Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension. Genetics and Molecular Research. 14(1). 1707–1717. 30 indexed citations
14.
Wang, Fengzhen, Dongsheng Zhang, Sunmin Jiang, et al.. (2014). Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma:vitroandvivostudy. Journal of drug targeting. 22(9). 849–858. 66 indexed citations
15.
Duitman, JanWillem, Roberta R. Ruela-de-Sousa, Kun Shi, et al.. (2014). Protease Activated Receptor-1 Deficiency Diminishes Bleomycin-Induced Skin Fibrosis. Molecular Medicine. 20(1). 410–416. 18 indexed citations
16.
Shi, Kun, Karla Queiroz, Jan Stap, Dick J. Richel, & C. Arnold Spek. (2013). Protease‐activated receptor‐2 induces migration of pancreatic cancer cells in an extracellular ATP‐dependent manner. Journal of Thrombosis and Haemostasis. 11(10). 1892–1902. 34 indexed citations
17.
Fu, Shaozhi, Jun Fan, Kun Shi, et al.. (2013). Biodegradable and Thermosensitive Monomethoxy Poly(ethylene glycol)–Poly(lactic acid) Hydrogel as a Barrier for Prevention of Post-Operative Abdominal Adhesion. Journal of Biomedical Nanotechnology. 10(3). 427–435. 30 indexed citations
19.
Shi, Kun. (2010). Teacher Development in China: A Study of Pedagogical Training in TCFL.. US-China education review. 7(8). 102–107. 1 indexed citations
20.
Wang, Xianmin, Wei Li, Kun Shi, et al.. (2009). [Changes of MMP-2,9 and TIMP-1 expressions in rats with pulmonary arterial hypertension after captopril and losartan interventions].. PubMed. 40(2). 255–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026